The reclassification of marijuana will change the way researchers will be able to study the drug, Dr. Kathryn Cunningham told the Daily News for a story on the U.S. Justice Department’s move to reclassify marijuana as a less dangerous drug. “By reducing it to Schedule III, we would facilitate the research and allow laboratories to gain much more information and knowledge about the impact of marijuana and its constituents on public health,” Cunningham said.